ICTS Co-Director Pat Winokur, MD, will lead a new clinical trial that is testing the ability of experimental adjuvants to boost the effectiveness of seasonal flu shots. Adjuvants are compounds added to vaccines to induce stronger and longer-lasting immune responses.
New study from a team of UI researchers in the Journal of the American Medical Association (JAMA) examined how top-performing hospitals implement rapid response teams (RRTs) and identified ways teams could be strengthened.
The long term effects of vaping are still in question. Alejandro Comellas, MD, director of the clinical research unit and pulmonologist, shares information about our new research study looking at the effects of vaping, or e-cigarettes, on growing lungs.
Philip Polgreen, MD, associate director of our mobile technology lab, collaborates with Aaron Miller, PhD, professor of epidemiology in the College of Public Health and Linnea Polgreen, PhD, associate professor of pharmacy practice in the College of Pharmacy to analyze which foods we choose to eat and how much of those foods we consume may be significantly different in obese people.
Jason Wilken, PT, PhD, associate director in our mobile technology lab, is helping people that have suffered a traumatic leg injury walk again by creating a custom carbon fiber custom dynamic orthoses brace.
Former Certificate in Clinical and Translational Science scholar Anya Kim studied the past academic year in Spain on a Fulbright scholarship. She will now pursue a joint medical and doctoral degree at Johns Hopkins University beginning in fall 2019.
Marlan Hansen, MD, professor of otolaryngology and neurosurgery, has been selected to serve a two-year term as chairperson of the Auditory System Study Section of the Center for Scientific Review at the National Institutes of Health (NIH).
Read the latest news and updates from the National Center for Advancing Translational Sciences (NCATS).
The Institute for Clinical and Translational Science will host a free 5-session seminar on Systematic Literature Reviews and Meta-Analyses.
Current KL2 Scholar Brad Rosen, DO, associate in internal medicine, has been named a Harry Shwachman Clinical Investigator awardee by the Cystic Fibrosis Foundation. This prestigious award is designed to provide the opportunity for promising, clinically training physicians with a commitment to research to develop into independent cystic fibrosis (CF) biomedical researchers.